ID: ALA3588907

Max Phase: Preclinical

Molecular Formula: C16H18N2O

Molecular Weight: 254.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NCCCN(C(=O)c1ccccc1)c1ccccc1

Standard InChI:  InChI=1S/C16H18N2O/c17-12-7-13-18(15-10-5-2-6-11-15)16(19)14-8-3-1-4-9-14/h1-6,8-11H,7,12-13,17H2

Standard InChI Key:  PWOTVYBICZWUOI-UHFFFAOYSA-N

Associated Targets(Human)

Alpha-2c adrenergic receptor 4876 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 254.33Molecular Weight (Monoisotopic): 254.1419AlogP: 2.68#Rotatable Bonds: 5
Polar Surface Area: 46.33Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.77CX LogP: 2.19CX LogD: -0.09
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.89Np Likeness Score: -1.17

References

1. Szőllősi E, Bobok A, Kiss L, Vass M, Kurkó D, Kolok S, Visegrády A, Keserű GM..  (2015)  Cell-based and virtual fragment screening for adrenergic α2C receptor agonists.,  23  (14): [PMID:25648685] [10.1016/j.bmc.2015.01.013]

Source